ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Pulmonary hypertension"

  • 2022 American Transplant Congress

    The Limited Role of Liver Transplantation in Porto-Pulmonary Hypertension Pathology

    J. Doi1, M. Fujiki2, S. Chaudhry1, T. Diago1, F. Aucejo1, C. Kwon1, B. Eghtesad3, C. Miller4, C. Quintini5, K. Hashimoto1

    1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland, OH, 3The Cleveland Clinic, Cleveland, OH, 4The Cleveland Clinic, Bratenahl, OH, 5Cleveland Clinic, Beachwood, OH

    *Purpose: Portopulmonary hypertension (POPH) refers to pulmonary artery hypertension (PH) as a consequence of portal hypertension with or without liver disease. Previous studies used pulmonary…
  • 2022 American Transplant Congress

    Direct Central Ambulatory Venoarterial Extracorporeal Membrane Oxygenation and Double Lung Transplantation without Graft Reduction with Extreme Mediastinal Shift

    A. Gorton1, S. Keshavamurthy2

    1Cardiothoracic Surgery, University of Kentucky, Lexington, KY, 2University of Kentucky, Lexington, KY

    *Purpose: Double Lung transplantation in the presence of extreme mediastinal shift can be technically challenging due to donor sizing and recipient factors.*Methods: We present the…
  • 2021 American Transplant Congress

    Right Ventricular Dysfunction After Heart Transplantation: When to Worry?

    S. Kim, J. Patel, M. Kittleson, T. Singer-Englar, N. Patel, R. Skorka, D. Chang, E. Kransdorf, M. Hamilton, B. Azarbal, L. Czer, D. Ramzy, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Right ventricular (RV) dysfunction after heart transplantation (HTx) is not uncommon. The cause of RV dysfunction may be due to inadequate preservation, high pulmonary…
  • 2021 American Transplant Congress

    Kidney Transplantation in Patients with Severe Pulmonary Hypertension: Not an Absolute Contraindication?

    B. Prajapati1, D. Gumber2, I. Moinuddin1, C. Bhati1, G. Gupta1, D. Grinnan3, D. Kumar1

    1Nephrology, Virginia Commonwealth University, Richmond, VA, 2Cardiology, Virginia Commonwealth University, Richmond, VA, 3Pulmonology, Virginia Commonwealth University, Richmond, VA

    *Purpose: Severe pulmonary arterial hypertension (PAH) as defined by a pulmonary artery systolic pressure (PASP) >50mmHg is associated with high peri-operative mortality and thus is…
  • 2020 American Transplant Congress

    Incidence, Clinical Correlates and Outcomes of Pulmonary Hypertension after Kidney Transplantation: Analysis of Linked U.S. Registry and Medicare Billing Claims

    K. Lentine1, S. Costa2, Y. Caliskan3, D. Levine4, J. Runo5, H. Te6, J. Rangaswami7, D. Dadhania8, D. Axelrod9, M. Schnitzler3, H. Xiao1, B. Kasiske10, J. Snyder10, T. Villines11

    1Department of Medicine, Saint Louis Univ, Saint Louis, MO, 2Dartmouth, Lebanon, NH, 3Saint Louis Univ, Saint Louis, MO, 4UT Health, San Antonio, TX, 5Univ of Wisconsin, Madison, WI, 6Univ of Chicago, Chicago, IL, 7Einstein Medical Ctr, Philadelphia, PA, 8Weill Cornell, New York, NY, 9Univ of Iowa, Iowa City, IA, 10SRTR, Minneapolis, MN, 11Univ of Virginia, Charlottesville, VA

    *Purpose: To describe the incidence and mortality implications of pulmonary hypertension (P-HTN) in a large, national cohort of US kidney transplant (KTx) recipients.*Methods: We examined…
  • 2020 American Transplant Congress

    Takotsubo Cardiomyopathy Following Liver Transplantation: A Single Center Experience

    O. Shamaa1, S. Jafri1, M. Shamaa2, K. Brown1, D. Venkat1

    1Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, 2General Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: Takotsubo cardiomyopathy also known as apical ballooning syndrome and stress-induced cardiomyopathy is a syndrome characterized by regional left ventricular systolic dysfunction that resembles myocardial…
  • 2020 American Transplant Congress

    Bilateral Lung Transplantation Combined with Cardiac Correction in Treatment of Severe Pulmonary Arterial Hypertension Complicated with Eisenmenger Syndrome in Puerpera, a Feasible Strategy for Future?

    J. Huang, Z. Wang, J. Chen

    Wuxi Lung Transplant Center, Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, China

    *Purpose: Though pregnancy is not recommended for patients with pulmonary arterial hypertension (PAH) in current guidelines, some patients do stick to parturition due to varies…
  • 2019 American Transplant Congress

    Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension

    C. Ju, Q. Lian, B. Wei, X. Xu, J. He, R. Chen

    State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China

    *Purpose: Heart-lung transplants (HLTx) is the only one effective strategy for advanced pulmonary arterial hypertension (PAH) with refractory right heart failure. But limited availability of…
  • 2018 American Transplant Congress

    The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis

    R. Deng, B. Huang, Y. Shi, Y. Ma.

    Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    Background: Portopulmonary hypertension(PPH) was once regarded as a contraindicaton in liver transplantation(LT).However,growing evidence indicated that PPH patients underwent LT may show similar outcomes compared to…
  • 2017 American Transplant Congress

    Preoperative Pulmonary Hypertension Is Not Associated with Adverse Outcomes After Lung Transplantation.

    S. Biswas Roy,1 M. Olson,2 D. Harned,1 P. Kang,3 R. Panchanathan,3 A. Hashimi,1 J. Huang,1 H. Abdelrazek,1 V. Patel,1 A. Omar,1 R. Bremner,1 M. Smith,1 R. Walia,1 A. Kalya.4

    1Norton Thoracic Institute, Phoenix; 2Grand Canyon University, Phoenix; 3University of Arizona, Phoenix; 4St. Joseph's Hospital and Medical Center, Phoenix

    Purpose: The effect of preoperative pulmonary hypertension (PH)[mdash]that is, mean pulmonary artery pressure (mPAP) of 25mmHg or higher[mdash]on lung transplantation (LTx) outcomes is debatable.Methods: We…
  • 1
  • 2
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences